Increases in resting heart rate are a recognised class effect of incretin-based therapies and have been reported with GLP-1 receptor agonists more broadly, as reflected in the Summary of Product Characteristics (SmPC) for licensed agents such as semaglutide (Wegovy) and liraglutide (Saxenda)
This article examines the evidence surrounding Ozempic-related gastroparesis, recovery timelines following discontinuation, management strategies, and when to seek medical advice, providing guidance aligned with UK clinical practice and MHRA recommendations
Im able to calm down, snuggle up, and promise myself that sleep will come when my body is ready again
This intramuscular shot can enhance cognitive function and focus, improve mental clarity and memory, increase energy levels and reduce fatigue, and even support addiction recovery and mood balance
By lowering inflammation, encouraging tissue repair, and guarding against oxidative damage, the combined effects of KPV and BPC-157 may promote CNS health
